Drug Res (Stuttg) 2019; 69(12): 695-698
DOI: 10.1055/a-0991-7684
Short Communication
© Georg Thieme Verlag KG Stuttgart · New York

Clozapine Disrupts Endothelial Nitric Oxide Signaling and Antioxidant System for its Cardiovascular Complications

Gayathri M. Nair
1   Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, India
,
Dona Sheba Skaria
1   Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, India
,
Teenu James
1   Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, India
,
S. K. Kanthlal
1   Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, India
› Author Affiliations
Further Information

Publication History

received 31 July 2019

accepted 05 August 2019

Publication Date:
09 September 2019 (online)

Abstract

Objective Many drugs in current practice require additional safety labels in order to prevent potential risks to the major organ system. Psychotropic agent clozapine has been reported to produce myocarditis and other cardiac complications on repeated use. Our study aimed to establish the role of clozapine in vascular damage associated with nitric oxide metabolism.

Method Isolated aortic strips incubated with clozapine at different dose levels were estimated for nitrite release and antioxidant systems such as glutathione and catalase. Vascular integrity assessment was performed by recording the acetylcholine induced relaxation of phenyephrine pre-contracted aorta.

Result From our study, it was found that clozapine depletes the nitric oxide level in the endothelium and enhance the oxidative stress. The aorta fails to relax completely after the addition of acetylcholine indicates the deranged eNOS signaling in the endothelium.

Conclusion From the experimental findings, it was concluded that clozapine could depress the eNOS regulation and thereby perhaps initiates cardiovascular complications through subsequent vascular events

 
  • References

  • 1 Bachmann CJ, Aagaard L, Bernardo M. et al. International trends in clozapine use: A study in 17 countries. Acta Psychiatr Scand 2017; 136: 37-51
  • 2 Otsuka Y, Idemoto K, Hosoda Y. et al. Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial. J Gen Fam Med 2019; 20: 114-117
  • 3 Qin X, Hou X, Zhang M. et al. Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs. Int J Mol Sci 2014; 15: 6641-6656
  • 4 Pechánová O, Bernátová I, Babál P. et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 2004; 22: 1551-1559
  • 5 Simon V, Sreerag KV, Sasikumar R. et al. High dose antibiotics induced hepatotoxicity and altered markers: An in-vitro liver slices study. Res J Pharm Technol 2017; 10: 1742-1745
  • 6 Vergnani L, Hatrik S, Ricci F. et al. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: Key role of L-arginine availability. Circulation 2000; 101: 1261-1266
  • 7 Machida T, Iizuka K, Hirafuji M. 5-Hydroxytryptamine and its receptors in systemic vascular walls. Biol Pharm Bull 2013; 36: 1416-1419
  • 8 Bunbupha S, Pakdeechote P, Kukongviriyapan U. et al. Asiatic acid reduces blood pressure by enhancing nitric oxide bioavailability with modulation of eNOS and p47phox expression in L-NAME-induced hypertensive rats. Phyther Res 2014; 28: 1506-1512
  • 9 Fayers KE, Cummings MH, Shaw KM. et al. Nitrate tolerance and the links with endothelial dysfunction and oxidative stress. Br J Clin Pharmacol 2003; 56: 620-628
  • 10 Chen QM, Morrissy S, Alpert JS. Oxidative Stress and Heart Failure. Compr Toxicol. Third Ed. 2017. 13–15 230-251